Concepedia

Vedran Radojčić

VR

23

Publications

1.4K

Citations

18

H-Index

2003

Active since

Affiliations

University of Utah(Current)

Huntsman Cancer Institute

Sidney Kimmel Comprehensive Cancer Center

University of Michigan

University of Minnesota

Vedran Radojčić is an author at University of Utah specializing in autoimmunity, medicine, and immunology.

ORCID

Top concepts

Publications per year

2003–2024

23

Publications

23

Blockade of individual Notch ligands and receptors controls graft-versus-host disease

Ivy Tran, Ashley R. Sandy, Alexis J. Carulli et al. · Journal of Clinical Investigation · 2013 · 167 citations · Full text

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report

Daniel Wolff, Vedran Radojčić, Robert Lafyatis et al. · Transplantation and Cellular Therapy · 2021 · 136 citations · Full text

Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease

Yi Zhang, Ashley R. Sandy, Jina Wang et al. · Blood · 2010 · 119 citations · Full text

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination

Vedran Radojčić, Karl Bezak, Mario Škarica et al. · Cancer Immunology Immunotherapy · 2009 · 108 citations · Full text

, , +9

Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease

Daniel Wolff, Corey Cutler, Stephanie J. Lee et al. · New England Journal of Medicine · 2024 · 106 citations

Rows per page

1–5 of 23